At long last, Novavax has secured a full FDA approval for its protein-based COVID-19 vaccine, though not in the broad ...

While the clearance is only for use in certain groups, Novavax’s long-awaited OK is still seen by analysts as a “win” for the ...

Novavax received Food and Drug Administration approval for its new, protein-based COVID-19 vaccine, and shares jumped 25% at the opening bell Monday.

Novavax (NVAX) shares climbed more than 17% premarket on Monday after the long-delayed approval of its COVID-19 vaccine from ...

WASHINGTON — The Trump administration’s effort to impose new requirements on Novavax’s COVID ... flu shot, “which has been tried and tested for more than 80 years.” Under federal law ...

The FDA recently asked Novavax to develop ... update their vaccine recipes to better match the latest COVID-19 variants that are circulating, just like flu shots are updated yearly.

WASHINGTON (AP) — The Trump administration’s effort to impose new requirements on Novavax’s COVID-19 vaccine — the ... target — just like flu vaccines. The FDA was on track to grant ...

The FDA recently asked Novavax to develop ... update their vaccine recipes to better match the latest COVID-19 variants that are circulating, just like flu shots are updated yearly.

Novavax's closely watched COVID-19 vaccine is on track for full approval after additional discussions with the FDA, the company said ... just like flu shots are updated yearly.

The Novavax vaccine ... coronavirus continually mutates, manufacturers follow instructions from FDA to make one change each year to their recipe — which strain to target — just like flu ...